Jeffrey Marciniak-Haynosch

Four years phage therapy research at Armata Pharma- has led me to pursue a PhD degree starting Fall 2021 in the United States. I’d like to speak with and welcome opportunities from other phage researchers in academia and industry, alike to push the frontiers of bacteriophage utility beyond that of human application.